Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27125590 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Inés Aznar-Peralta und 5 weiteren Autor:innen. Beteiligte Einrichtung: GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Cirrhosis, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Health Carlos III.
Abstract (Originalsprache)
Early detection of hepatocellular carcinoma (HCC) is crucial for curative treatment, yet current screening strategies for high-risk liver cirrhosis (LC) patients lack sufficient sensitivity. This study evaluates plasma cell-free DNA(cfDNA) concentration and fragmentomics as biomarkers to improve HCC diagnosis and prognosis. Plasma samples from 39 HCC and 46 LC patients were analyzed for cfDNA concentration and fragment patterns. A multivariate logistic regression model (CMAC), integrating cfDNA concentration, mononucleosome proportion (%MN), alpha-fetoprotein (AFP), and c-reactive protein (CRP), was developed and validated using Leave-One-Out Cross-Validation and bootstrapping. HCC patients exhibited significantly higher cfDNA concentrations (p < 0.0001) and longer fragment lengths (p < 0.05) compared to LC patients. The CMAC model demonstrated superior diagnostic performance (AUROC = 0.946) compared to AFP alone (AUROC = 0.777, p < 0.001). Notably, in early-stage HCC, the CMAC model remained highly accurate (AUROC = 0.941), whereas AFP failed to reach statistical significance. Higher CMAC scores were significantly associated with advanced BCLC stages (p = 0.009), lymphovascular invasion (p = 0.0063) and reduced overall survival (p = 0.0037). Integration of cfDNA analysis with established clinical markers in the CMAC model shows promise as a complementary tool for the early detection of HCC in LC patients. Validation in larger, multicenter cohorts will be necessary to confirm these findings and their clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.
- Digestive System Unit, Costa del Sol University Hospital, 29603 Marbella, Spain.
- Department of Pathology, San Cecilio Clinical University Hospital-Instituto de Investigación Biosanitaria ibs GRANADA, 18012 Granada, Spain.
- Department of Pathology, Virgen de las Nieves University Hospital-Instituto de Investigación Biosanitaria ibs GRANADA, 18012 Granada, Spain.
- Research Support Network, Scientific Research Coordination, National Autonomous University of Mexico, Mexico City 04510, Mexico.
- Molecular-Clinical Laboratory, University of Buenos Aires (UBA)-National Council for Scientific and Technical Research (CONICET), Buenos Aires C1053, Argentina.
ORCID-Profile: Inés Aznar-Peralta, Javier López Hidalgo, Cristobal Fresno, Valeria Denninghoff, María José Serrano
Förderung
- Institute of Health Carlos III
Zitieren
APA
Aznar-Peralta, I., Roa-Colomo, A., López Hidalgo, J., Fresno, C., Denninghoff, V., & José Serrano, M. (2026). Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125590
Vancouver
Aznar-Peralta I, Roa-Colomo A, López Hidalgo J, Fresno C, Denninghoff V, José Serrano M. Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125590
BibTeX
@article{AznarPeralta2026,
author = {Aznar-Peralta, Inés and Roa-Colomo, Amparo and López Hidalgo, Javier and Fresno, Cristobal and Denninghoff, Valeria and José Serrano, María},
title = {Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27125590}
}
EUVIMED